[Atheroma plaque stabilization: a new concept based on the dynamic biology of atherosclerosis]

Area of Science:

• Cardiovascular Medicine
• Medical Imaging
• Pharmacology

Background:

• Acute coronary syndromes often result from thrombus formation on disrupted atherosclerotic plaques.
• Plaque stabilization, involving lipid core reduction and fibrous cap thickening, is a proposed mechanism for clinical benefits of anti-atherosclerotic therapies.
• Lipid-lowering agents may reduce cardiovascular events by stabilizing plaques, even without significant lesion modification.

Purpose of the Study:

• To explore the mechanisms behind the clinical benefits of anti-atherosclerotic strategies, focusing on plaque stabilization.
• To review the role of various drug classes in reducing plaque burden and cardiovascular events.
• To highlight the contribution of non-invasive imaging in assessing atherosclerotic plaque characteristics.

Main Methods:

• Review of existing literature on atherosclerosis, plaque stabilization, and cardiovascular event reduction.
• Discussion of non-invasive imaging modalities (vascular ultrasound, MRI, coronary computed tomography) for plaque assessment.
• Analysis of the effects of drug classes (statins, ACE inhibitors, beta-blockers, antithrombotics) on plaque burden and endothelial function.

Main Results:

• Plaque stabilization is a recognized mechanism contributing to the efficacy of anti-atherosclerotic treatments.
• Non-invasive imaging can assess plaque characteristics, including vulnerability, and monitor treatment effects.
• Several drug classes demonstrate the ability to reduce plaque burden and cardiovascular events, partly through plaque stabilization and improved endothelial function.

Conclusions:

• Plaque stabilization is a significant factor in managing atherosclerotic disease and preventing cardiovascular events.
• Pharmacological interventions and improved endothelial function play crucial roles in mitigating atherosclerosis progression.
• Advanced imaging techniques are vital for evaluating plaque stability and guiding therapeutic strategies.